Suggestions
Jeff Gimble
Chief Scientific Officer at LaCell LLC
Jeff Gimble is a prominent figure in the field of regenerative medicine and currently serves as the Chief Scientific Officer at LaCell LLC, a position he has held since June 2013. He co-founded LaCell in 2010 alongside Dr. Xiying Wu, aiming to advance the isolation and clinical application of stromal and stem cells derived from adipose tissue, bone, and bone marrow.13
Educational Background
Dr. Gimble earned both his M.D. and Ph.D. from Yale University, where he initiated his extensive research career that spans over three decades. His academic contributions include numerous faculty positions, notably as an Adjunct Professor at Tulane University since December 2009 and as a former professor at the Pennington Biomedical Research Center from 2003 to 2013.12
Research Focus
His research primarily focuses on the isolation, characterization, and clinical translation of stem cells, which has resulted in over 200 published manuscripts. This prolific output underscores his significant impact on the field of stem cell research.23 Prior to his role at LaCell, Dr. Gimble was also involved with Artecel Sciences, where he served as Chief Scientific Officer from 2000 to 2003.1
Contributions to Biotechnology
In addition to his work at LaCell, Dr. Gimble co-founded Obatala Sciences in 2017, further extending his influence in the biotechnology sector by providing expertise to both academic institutions and biotech companies.23 His leadership and innovative research continue to shape advancements in regenerative medicine and cellular therapies.
In summary, Jeff Gimble's career is marked by significant academic achievements and contributions to the biotechnology industry, particularly in the area of stem cell research and its applications in regenerative medicine.
